Merit Medical Systems, Inc. (MMSI) Stock Analysis
Recovery setup
Healthcare · Medical Instruments & Supplies
Hold if already holding. Not a fresh buy at $67.51, but acceptable to hold if already in. Reason: Below 200-MA, MA slope -4.1%/30d (confirmed downtrend).
Merit Medical Systems manufactures proprietary medical devices for cardiovascular (peripheral intervention, cardiac intervention, custom solutions, OEM) and endoscopy procedures globally. US sales accounted for 60% of net sales in 2025; China is the largest international market... Read more
Hold if already holding. Not a fresh buy at $67.51, but acceptable to hold if already in. Reason: Below 200-MA, MA slope -4.1%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 62. Maintain position. Not compelling to add more. Score 6.0/10, moderate confidence.
Passes 7/9 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 51d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated 2026-06-09Recent Developments — Merit Medical Systems, Inc.
Latest news
- NEWS Merit Medical Systems (MMSI) Reports Earnings Tomorrow: What To Expect - StockStory — StockStory neutral
- NEWS Merit Medical Systems (MMSI) Reports Earnings Tomorrow: What To Expect - FinancialContent — FinancialContent neutral
- NEWS Crown Advisors Management Inc. Purchases Shares of 30,000 Merit Medical Systems, Inc. $MMSI - MarketBeat — MarketBeat positive
- NEWS Merit Medical Systems stock hits 52-week low at $66.33 By Investing.com - Investing.com Canada — Investing.com Canada negative
- NEWS Here's why you should add Merit Medical stock to your portfolio now - MSN — MSN positive
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $67.51, but acceptable to hold if already in. Reason: Below 200-MA, MA slope -4.1%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 62. Maintain position. Not compelling to add more. Target $77.90 (+15.4%), stop $63.59 (−6.2%), A.R:R 1.3:1. Score 6.0/10, moderate confidence.
Take-profit target: $77.90 (+15.4% upside). Target $77.90 (+15.4%), stop $63.59 (−6.2%), A.R:R 1.3:1. Stop-loss: $63.59.
Below 200-MA, MA slope -4.1%/30d (confirmed downtrend).
Merit Medical Systems, Inc. trades at a P/E of 28.5 (forward 15.0). TrendMatrix value score: 6.5/10. Verdict: Hold.
17 analysts cover MMSI with a consensus score of 4.2/5. Average price target: $90.
What does Merit Medical Systems, Inc. do?Merit Medical Systems manufactures proprietary medical devices for cardiovascular (peripheral intervention, cardiac...
Merit Medical Systems manufactures proprietary medical devices for cardiovascular (peripheral intervention, cardiac intervention, custom solutions, OEM) and endoscopy procedures globally. US sales accounted for 60% of net sales in 2025; China is the largest international market but subject to VBP pricing pressure since 2022. Recent acquisitions include Cook Medical assets and Pentax of America.